Indian Pharmaceuticals & Biotech Healthy high growth potential

Rubicon Research

Market Cap: ₹301.1b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹266.7b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Sakar Healthcare

Market Cap: ₹20.1b

Research, develops, manufactures, and sells pharmaceutical products in India.

Aether Industries

Market Cap: ₹219.6b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

CORONA Remedies

Market Cap: ₹128.6b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

Anthem Biosciences

Market Cap: ₹519.9b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

Senores Pharmaceuticals

Market Cap: ₹68.8b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Emcure Pharmaceuticals

Market Cap: ₹353.2b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹387.3b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Laurus Labs

Market Cap: ₹1.0t

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

Supriya Lifescience

Market Cap: ₹62.9b

Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

Shilpa Medicare

Market Cap: ₹168.2b

Offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.